Clinical trial
S0031, ZD 1839 in Treating Patients With Advanced Cancer of the Urinary Tract
NCT00014144 · SWOG Cancer Research Network, Other · Completed
Key facts
| NCT number | NCT00014144 |
|---|---|
| Title | S0031, ZD 1839 in Treating Patients With Advanced Cancer of the Urinary Tract |
| Official title | Evaluation of ZD1839 (NSC #715055) for Advanced Transitional Cell Carcinoma of the Urothelium, Phase II |
| Lead sponsor | SWOG Cancer Research Network, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Bladder Cancer, Transitional Cell Cancer of the Renal Pelvis and Ureter, Urethral Cancer |
| Intervention type | Drug |
| Interventions | gefitinib |
| Enrollment | 31 |
| Start date | Feb 1, 2001 |
| Primary completion | May 1, 2003 |
| Completion | Dec 1, 2007 |
| First posted | Oct 15, 2003 |
| Last update posted | Oct 8, 2012 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: